# Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia

> **NCT01211847** · PHASE2 · COMPLETED · sponsor: **Essentialis, Inc.** · enrollment: 44 (actual)

## Conditions studied

- Hypertriglyceridemia
- Dyslipidemia

## Interventions

- **DRUG:** Diazoxide Choline Controlled-Release Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01211847
- **Lead sponsor:** Essentialis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2014-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01211847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01211847, "Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01211847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*